<code id='8E5F6CB625'></code><style id='8E5F6CB625'></style>
    • <acronym id='8E5F6CB625'></acronym>
      <center id='8E5F6CB625'><center id='8E5F6CB625'><tfoot id='8E5F6CB625'></tfoot></center><abbr id='8E5F6CB625'><dir id='8E5F6CB625'><tfoot id='8E5F6CB625'></tfoot><noframes id='8E5F6CB625'>

    • <optgroup id='8E5F6CB625'><strike id='8E5F6CB625'><sup id='8E5F6CB625'></sup></strike><code id='8E5F6CB625'></code></optgroup>
        1. <b id='8E5F6CB625'><label id='8E5F6CB625'><select id='8E5F6CB625'><dt id='8E5F6CB625'><span id='8E5F6CB625'></span></dt></select></label></b><u id='8E5F6CB625'></u>
          <i id='8E5F6CB625'><strike id='8E5F6CB625'><tt id='8E5F6CB625'><pre id='8E5F6CB625'></pre></tt></strike></i>

          fashion

          fashion

          author:explore    Page View:1585
          Elf Bar disposable vape flavored vaping e-cigarette products are displayed in a convenience store.
          The FDA is ramping up its efforts to force vape shops and other retailers to stop selling Elf Bar and Esco Bar products. PATRICK T. FALLON/AFP via Getty Images

          WASHINGTON — The Food and Drug Administration is ramping up its efforts to force vape shops and other retailers to stop selling unauthorized disposable vape brands that are increasingly popular with young people.

          The FDA recently issued 189 formal warning letters to shops selling two brands of vape products, Elf Bar and Esco Bars, the agency announced in a press release Thursday. The FDA has not authorized either brand, both of which are ubiquitous in gas stations and smoke shops around the country. They are therefore illegal to sell.

          advertisement

          “This latest blitz should be a wake-up call for retailers of Elf Bar and Esco Bars products nationwide,” said Brian King, the head of the FDA’s tobacco center in a statement announcing the blitz.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Unique patient identifier: Experts argue the benefits, pitfalls
          Unique patient identifier: Experts argue the benefits, pitfalls

          Therehasbeenlong-standingdebateintheUSoverwhethertoimplementauniquepatientidentifiersystem.EvanVucci

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Top private equity targets in 2023: cardiology, clinical trials, lasers

          AdobeBysomemeasures,privateequityinvestmentlaggedin2023,ayearmarkedbygrowingdistressandhigh-profiled